GIKLY Stock: Grifols, S.A. Stock Price, Analysis & Insights
Get live GIKLY stock price $5.69, comprehensive Grifols, S.A. stock analysis, charts, news, and expert forecast. Real-time GIKLY stock data and investment insights.
Loading chart data...
Grifols, S.A. (GIKLY) Overview
Grifols, S.A. (GIKLY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, GIKLY trades at $5.69 with a market capitalization of 14.95B . Over the past 52 weeks, GIKLY has traded between $5.11 and $7.49 , with the current price positioned at approximately 24% of this range . The stock currently ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 14.95B
- Current price: $5.69
- 52-week range: $5.11 - $7.49
- P/E ratio: 16.26
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Grifols, S.A. is a company dedicated to the acquisition, production, processing, and distribution of therapeutic goods, with a primary focus on plasma-derived medicines. Its operations are structured across several key divisions: Bioscience, Hospital...
Company Information
- CEO
- Jose Ignacio Abia Buenache
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 23833
Contact Information
- Website
- https://www.grifols.com
- Address
- Avinguda de la Generalitat, 152
- Country
- ES
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.3)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Grifols, S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Grifols, S.A.
- ⚠Investors should consider how Grifols, S.A. fits within their overall portfolio allocation
Market Cap
14.95B
P/E Ratio (TTM)
16.26
Beta
1.17
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare GIKLY with peer companies:
- Price
- $13.25
- Market cap
- 23.74B
- Price
- $13.21
- Market cap
- 23.67B
- Price
- $8.03
- Market cap
- 9.47B
- Price
- $1.05
- Market cap
- 11.98B
- Price
- $45.17
- Market cap
- 12.13B
- Price
- $82.75
- Market cap
- 11.66B
- Price
- $37.99
- Market cap
- 21.38B
- Price
- $15.10
- Market cap
- 12.82B
- Price
- $4.40
- Market cap
- 18.22B
- Price
- $7.49
- Market cap
- 15.44B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.